Thursday, September 24, 2020

Cipla gets final nod from USFDA for multiple sclerosis drug

Cipla gets final nod from USFDA for multiple sclerosis drug The newly approved product is a generic therapeutic equivalent version of Biogen IDEC Inc#39;#39;s Tecfidera.

from Moneycontrol Business News https://ift.tt/32ZecRt

No comments:

Post a Comment

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...